Indobufen is a platelet aggregation inhibitor, which mainly acts by reversibly inhibiting platelet cyclooxygenase to reduce the production of thromboxane B2.
The mitebufen is a platelet aggregation inhibitor that acts mainly by reversible inhibition of platelet cyclooxidation enzymes, which reduces the production of thrombosin B2.
Indole Bufen is an inhibitor of platelet aggregation. It can reduce the production of thromboxane B2 by reversibly inhibiting the cyclooxygenase of platelets.